Cite
HARVARD Citation
Subudhi, S. et al. (2015). Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].